Tags

Type your tag names separated by a space and hit enter

Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.
JAMA Netw Open. 2022 10 03; 5(10):e2238871.JN

Abstract

Importance

Data on the association of COVID-19 vaccination with intensive care unit (ICU) admission and outcomes of patients with SARS-CoV-2-related pneumonia are scarce.

Objective

To evaluate whether COVID-19 vaccination is associated with preventing ICU admission for COVID-19 pneumonia and to compare baseline characteristics and outcomes of vaccinated and unvaccinated patients admitted to an ICU.

Design, Setting, and Participants

This retrospective cohort study on regional data sets reports: (1) daily number of administered vaccines and (2) data of all consecutive patients admitted to an ICU in Lombardy, Italy, from August 1 to December 15, 2021 (Delta variant predominant). Vaccinated patients received either mRNA vaccines (BNT162b2 or mRNA-1273) or adenoviral vector vaccines (ChAdOx1-S or Ad26.COV2). Incident rate ratios (IRRs) were computed from August 1, 2021, to January 31, 2022; ICU and baseline characteristics and outcomes of vaccinated and unvaccinated patients admitted to an ICU were analyzed from August 1 to December 15, 2021.

Exposures

COVID-19 vaccination status (no vaccination, mRNA vaccine, adenoviral vector vaccine).

Main Outcomes and Measures

The incidence IRR of ICU admission was evaluated, comparing vaccinated people with unvaccinated, adjusted for age and sex. The baseline characteristics at ICU admission of vaccinated and unvaccinated patients were investigated. The association between vaccination status at ICU admission and mortality at ICU and hospital discharge were also studied, adjusting for possible confounders.

Results

Among the 10 107 674 inhabitants of Lombardy, Italy, at the time of this study, the median [IQR] age was 48 [28-64] years and 5 154 914 (51.0%) were female. Of the 7 863 417 individuals who were vaccinated (median [IQR] age: 53 [33-68] years; 4 010 343 [51.4%] female), 6 251 417 (79.5%) received an mRNA vaccine, 550 439 (7.0%) received an adenoviral vector vaccine, and 1 061 561 (13.5%) received a mix of vaccines and 4 497 875 (57.2%) were boosted. Compared with unvaccinated people, IRR of individuals who received an mRNA vaccine within 120 days from the last dose was 0.03 (95% CI, 0.03-0.04; P < .001), whereas IRR of individuals who received an adenoviral vector vaccine after 120 days was 0.21 (95% CI, 0.19-0.24; P < .001). There were 553 patients admitted to an ICU for COVID-19 pneumonia during the study period: 139 patients (25.1%) were vaccinated and 414 (74.9%) were unvaccinated. Compared with unvaccinated patients, vaccinated patients were older (median [IQR]: 72 [66-76] vs 60 [51-69] years; P < .001), primarily male individuals (110 patients [79.1%] vs 252 patients [60.9%]; P < .001), with more comorbidities (median [IQR]: 2 [1-3] vs 0 [0-1] comorbidities; P < .001) and had higher ratio of arterial partial pressure of oxygen (Pao2) and fraction of inspiratory oxygen (FiO2) at ICU admission (median [IQR]: 138 [100-180] vs 120 [90-158] mm Hg; P = .007). Factors associated with ICU and hospital mortality were higher age, premorbid heart disease, lower Pao2/FiO2 at ICU admission, and female sex (this factor only for ICU mortality). ICU and hospital mortality were similar between vaccinated and unvaccinated patients.

Conclusions and Relevance

In this cohort study, mRNA and adenoviral vector vaccines were associated with significantly lower risk of ICU admission for COVID-19 pneumonia. ICU and hospital mortality were not associated with vaccinated status. These findings suggest a substantial reduction of the risk of developing COVID-19-related severe acute respiratory failure requiring ICU admission among vaccinated people.

Authors+Show Affiliations

Dipartimento di Anestesia, Rianimazione ed Emergenza-Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.Dipartimento di Anestesia, Rianimazione ed Emergenza-Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.Dipartimento di Anestesia, Rianimazione ed Emergenza-Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.Department of Anesthesia and Intensive Care Medicine, ASST Monza Ospedale San Gerardo, Monza, Italy. School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.Dipartimento di Anestesia, Rianimazione ed Emergenza-Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.Azienda Ospedaliera Ospedale di Circolo e Fondazione Macchi, Varese, Italy. Università degli Studi dell'Insubria, Varese, Italy.Dipartimento di Anestesia e Rianimazione, ASST Mantova Ospedale Carlo Poma, Mantova Italy.Department of Anesthesiology and Intensive Care, ASST Fatebenefratelli Sacco Luigi Sacco Hospital, Polo Universitario, Milan, Italy.Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Clinical and Research Centre, Rozzano, Italy. Humanitas University, Pieve Emanuele, Italy.Directorate General for Health, Lombardy Region, Milano, Italy.Department of Anesthesia and Intensive Care, San Paolo Hospital, Milano, Italy. Department of Health Sciences, University of Milan, Milano, Italy.Dipartimento di Anestesia e Rianimazione ASST Lecco Ospedale di Lecco, Lecco, Italy.Department of Anesthesia and Intensive Care Medicine, ASST Monza Ospedale San Gerardo, Monza, Italy. School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.Terapia Intensiva-Neuroanestesia e Rianimazione. Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.Dipartimento di Anestesia e Rianimazione, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.Department of Anaesthesia and Intensive Care, ASST Papa Giovanni XXIII, Bergamo, Italy.Dipartimento Di Emergenza, Rianimazione, Anestesia-UO Anestesia e Rianimazione 2-ASST Lariana Ospedale Sant'Anna, Como, Italy.Department of Anaesthesia and Intensive Care, ASST Papa Giovanni XXIII, Bergamo, Italy.Dipartimento di Anestesia, Rianimazione ed Emergenza-Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.Humanitas University, Pieve Emanuele, Italy.Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. Department of Anesthesia and critical care, ASST Ovest Milanese Ospedale Nuovo di Legnano, Legnano, Italy.Anestesia e Rianimazione 1, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Dipartimento di Scienze Clinico-Chirurgiche Diagnostiche e Pediatriche, Università degli Studi di Pavia, Pavia, Italy.Anestesia e Rianimazione 1, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.Dipartimento di Anestesia e Rianimazione, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.SC Anestesia e Rianimazione II, Ospedale San Carlo Borromeo, ASST Santi Paolo e Carlo-Polo Universitario, Milano, Italy.Department of Anesthesia, Critical Care and Emergency, Spedali Civili University Hospital, Brescia, Italy.Department of Anaesthesia and Intensive Care Medicine, IRCCS Humanitas Clinical and Research Centre, Rozzano, Italy. Humanitas University, Pieve Emanuele, Italy.Department of Anesthesia, Critical Care and Emergency, Spedali Civili University Hospital, Brescia, Italy. Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milano, Italy.Azienda Ospedaliera Ospedale di Circolo e Fondazione Macchi, Varese, Italy. Università degli Studi dell'Insubria, Varese, Italy.Dipartimento di Anestesia e Rianimazione ASST Cremona Ospedale di Cremona, Cremona, Italy.School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy. Dipartimento di Anestesia e Rianimazione, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.Dipartimento di Anestesia, Rianimazione ed Emergenza-Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.No affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

36301541

Citation

Grasselli, Giacomo, et al. "Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy." JAMA Network Open, vol. 5, no. 10, 2022, pp. e2238871.
Grasselli G, Zanella A, Carlesso E, et al. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy. JAMA Netw Open. 2022;5(10):e2238871.
Grasselli, G., Zanella, A., Carlesso, E., Florio, G., Canakoglu, A., Bellani, G., Bottino, N., Cabrini, L., Castelli, G. P., Catena, E., Cecconi, M., Cereda, D., Chiumello, D., Forastieri, A., Foti, G., Gemma, M., Giudici, R., Grazioli, L., Lombardo, A., ... Pesenti, A. (2022). Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy. JAMA Network Open, 5(10), e2238871. https://doi.org/10.1001/jamanetworkopen.2022.38871
Grasselli G, et al. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy. JAMA Netw Open. 2022 10 3;5(10):e2238871. PubMed PMID: 36301541.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy. AU - Grasselli,Giacomo, AU - Zanella,Alberto, AU - Carlesso,Eleonora, AU - Florio,Gaetano, AU - Canakoglu,Arif, AU - Bellani,Giacomo, AU - Bottino,Nicola, AU - Cabrini,Luca, AU - Castelli,Gian Paolo, AU - Catena,Emanuele, AU - Cecconi,Maurizio, AU - Cereda,Danilo, AU - Chiumello,Davide, AU - Forastieri,Andrea, AU - Foti,Giuseppe, AU - Gemma,Marco, AU - Giudici,Riccardo, AU - Grazioli,Lorenzo, AU - Lombardo,Andrea, AU - Lorini,Ferdinando Luca, AU - Madotto,Fabiana, AU - Mantovani,Alberto, AU - Mistraletti,Giovanni, AU - Mojoli,Francesco, AU - Mongodi,Silvia, AU - Monti,Gianpaola, AU - Muttini,Stefano, AU - Piva,Simone, AU - Protti,Alessandro, AU - Rasulo,Frank, AU - Scandroglio,Anna Mara, AU - Severgnini,Paolo, AU - Storti,Enrico, AU - Fumagalli,Roberto, AU - Pesenti,Antonio, AU - ,, Y1 - 2022/10/03/ PY - 2022/10/27/entrez PY - 2022/10/28/pubmed PY - 2022/11/1/medline SP - e2238871 EP - e2238871 JF - JAMA network open JO - JAMA Netw Open VL - 5 IS - 10 N2 - Importance: Data on the association of COVID-19 vaccination with intensive care unit (ICU) admission and outcomes of patients with SARS-CoV-2-related pneumonia are scarce. Objective: To evaluate whether COVID-19 vaccination is associated with preventing ICU admission for COVID-19 pneumonia and to compare baseline characteristics and outcomes of vaccinated and unvaccinated patients admitted to an ICU. Design, Setting, and Participants: This retrospective cohort study on regional data sets reports: (1) daily number of administered vaccines and (2) data of all consecutive patients admitted to an ICU in Lombardy, Italy, from August 1 to December 15, 2021 (Delta variant predominant). Vaccinated patients received either mRNA vaccines (BNT162b2 or mRNA-1273) or adenoviral vector vaccines (ChAdOx1-S or Ad26.COV2). Incident rate ratios (IRRs) were computed from August 1, 2021, to January 31, 2022; ICU and baseline characteristics and outcomes of vaccinated and unvaccinated patients admitted to an ICU were analyzed from August 1 to December 15, 2021. Exposures: COVID-19 vaccination status (no vaccination, mRNA vaccine, adenoviral vector vaccine). Main Outcomes and Measures: The incidence IRR of ICU admission was evaluated, comparing vaccinated people with unvaccinated, adjusted for age and sex. The baseline characteristics at ICU admission of vaccinated and unvaccinated patients were investigated. The association between vaccination status at ICU admission and mortality at ICU and hospital discharge were also studied, adjusting for possible confounders. Results: Among the 10 107 674 inhabitants of Lombardy, Italy, at the time of this study, the median [IQR] age was 48 [28-64] years and 5 154 914 (51.0%) were female. Of the 7 863 417 individuals who were vaccinated (median [IQR] age: 53 [33-68] years; 4 010 343 [51.4%] female), 6 251 417 (79.5%) received an mRNA vaccine, 550 439 (7.0%) received an adenoviral vector vaccine, and 1 061 561 (13.5%) received a mix of vaccines and 4 497 875 (57.2%) were boosted. Compared with unvaccinated people, IRR of individuals who received an mRNA vaccine within 120 days from the last dose was 0.03 (95% CI, 0.03-0.04; P < .001), whereas IRR of individuals who received an adenoviral vector vaccine after 120 days was 0.21 (95% CI, 0.19-0.24; P < .001). There were 553 patients admitted to an ICU for COVID-19 pneumonia during the study period: 139 patients (25.1%) were vaccinated and 414 (74.9%) were unvaccinated. Compared with unvaccinated patients, vaccinated patients were older (median [IQR]: 72 [66-76] vs 60 [51-69] years; P < .001), primarily male individuals (110 patients [79.1%] vs 252 patients [60.9%]; P < .001), with more comorbidities (median [IQR]: 2 [1-3] vs 0 [0-1] comorbidities; P < .001) and had higher ratio of arterial partial pressure of oxygen (Pao2) and fraction of inspiratory oxygen (FiO2) at ICU admission (median [IQR]: 138 [100-180] vs 120 [90-158] mm Hg; P = .007). Factors associated with ICU and hospital mortality were higher age, premorbid heart disease, lower Pao2/FiO2 at ICU admission, and female sex (this factor only for ICU mortality). ICU and hospital mortality were similar between vaccinated and unvaccinated patients. Conclusions and Relevance: In this cohort study, mRNA and adenoviral vector vaccines were associated with significantly lower risk of ICU admission for COVID-19 pneumonia. ICU and hospital mortality were not associated with vaccinated status. These findings suggest a substantial reduction of the risk of developing COVID-19-related severe acute respiratory failure requiring ICU admission among vaccinated people. SN - 2574-3805 UR - https://www.unboundmedicine.com/medline/citation/36301541/Association_of_COVID_19_Vaccinations_With_Intensive_Care_Unit_Admissions_and_Outcome_of_Critically_Ill_Patients_With_COVID_19_Pneumonia_in_Lombardy_Italy_ DB - PRIME DP - Unbound Medicine ER -